Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study.
Gupte AN, Kumar P, Araújo-Pereira M, Kulkarni V, Paradkar M, Pradhan N, Menon P, Padmapriyadarsini C, Hanna LE, Yogendra Shivakumar SVB, Rockwood N, Du Bruyn E, Karyakarte R, Gaikwad S, Bollinger R, Golub J, Gupte N, Viswanathan V, Wilkinson RJ, Mave V, Babu S, Kornfeld H, Andrade BB, Gupta A.
Gupte AN, et al. Among authors: kornfeld h.
Eur Respir J. 2022 Apr 21;59(4):2100905. doi: 10.1183/13993003.00905-2021. Print 2022 Apr.
Eur Respir J. 2022.
PMID: 34711538
Free PMC article.